Tags

Type your tag names separated by a space and hit enter

The novel agent, alpha lipoic acid, can cause the development of insulin autoimmune syndrome.
Intern Med 2007; 46(17):1321-2IM

Authors

No affiliation info available

Pub Type(s)

Editorial

Language

eng

PubMed ID

17827827

Citation

Uchigata, Yasuko. "The Novel Agent, Alpha Lipoic Acid, Can Cause the Development of Insulin Autoimmune Syndrome." Internal Medicine (Tokyo, Japan), vol. 46, no. 17, 2007, pp. 1321-2.
Uchigata Y. The novel agent, alpha lipoic acid, can cause the development of insulin autoimmune syndrome. Intern Med. 2007;46(17):1321-2.
Uchigata, Y. (2007). The novel agent, alpha lipoic acid, can cause the development of insulin autoimmune syndrome. Internal Medicine (Tokyo, Japan), 46(17), pp. 1321-2.
Uchigata Y. The Novel Agent, Alpha Lipoic Acid, Can Cause the Development of Insulin Autoimmune Syndrome. Intern Med. 2007;46(17):1321-2. PubMed PMID: 17827827.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The novel agent, alpha lipoic acid, can cause the development of insulin autoimmune syndrome. A1 - Uchigata,Yasuko, Y1 - 2007/09/03/ PY - 2007/9/11/pubmed PY - 2007/9/21/medline PY - 2007/9/11/entrez SP - 1321 EP - 2 JF - Internal medicine (Tokyo, Japan) JO - Intern. Med. VL - 46 IS - 17 SN - 1349-7235 UR - https://www.unboundmedicine.com/medline/citation/17827827/The_novel_agent_alpha_lipoic_acid_can_cause_the_development_of_insulin_autoimmune_syndrome_ L2 - https://joi.jlc.jst.go.jp/JST.JSTAGE/internalmedicine/46.0221?from=PubMed DB - PRIME DP - Unbound Medicine ER -